WallStSmart
DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ: DMAA · FINANCIAL SERVICES · SHELL COMPANIES

$10.88
+0.28% today

Updated 2026-10-09

Market cap
$263.40M
P/E ratio
60.28
P/S ratio
—
EPS (TTM)
$0.18
Dividend yield
—
52W range
$10 – $11
Volume
0.0M

WallStSmart proprietary scores

27
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D
6.5
Quality
B
3.5
Profitability
D
4.0
Valuation
C
2/9
Piotroski F-Score
Weak
19.1
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →274 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Altman Z 19.10 — safe zone
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-244610.00
- P/E 60.28x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow
Metric20242025TTM
Revenue—$0.00$0.00
Net income$-479.00$5.94M$1.73M
EPS——$0.18
Free cash flow$-172270.00$-539187.00$-244610.00
Profit margin———

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
DMAA$263.40M273.73.54.06.5—Avoid
BRK-B$1.08T747.37.55.08.0—Strong Buy
BRK-A$1.08T747.37.55.08.5—Strong Buy
JPM$880.60B8110.08.05.73.0—Exceptional Buy
V$695.82B686.710.04.35.0—Strong Buy
MA$496.33B727.310.05.05.5—Strong Buy

Smart narrative

Drugs Made In America Acquisition Corp. Ordinary Shares trades at $10.88. representing a P/E of 60.28x trailing earnings. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 19.10, it sits in the safe zone.

Frequently asked questions

What is Drugs Made In America Acquisition Corp. Ordinary Shares's stock price?

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) trades at $10.88, on a P/E of 60.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Drugs Made In America Acquisition Corp. Ordinary Shares overvalued?

Drugs Made In America Acquisition Corp. Ordinary Shares carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Drugs Made In America Acquisition Corp. Ordinary Shares's Altman Z-Score is 19.10, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorFINANCIAL SERVICES
IndustrySHELL COMPANIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE2.84%
Beta—
50D MA$10.78
200D MA$10.59
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.0M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—